[et_pb_section fb_built=”1″ next_background_color=”#ffffff” _builder_version=”4.27.4″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”#001970 0%|#303f9f 100%” bottom_divider_style=”wave2″ bottom_divider_height=”50px” bottom_divider_height_tablet=”50px” bottom_divider_height_phone=”25px” bottom_divider_height_last_edited=”on|phone” da_disable_devices=”off|off|off” locked=”off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][dipi_dual_heading first_heading=”A\/Prof Amit Khot” second_heading=”Consultant Haematologist at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne” heading_display=”column” _builder_version=”4.27.4″ _module_preset=”default” first_heading_font=”|700|||||||” first_heading_text_color=”#ffffff” first_heading_font_size=”40px” second_heading_text_color=”#E8EAF6″ first_heading_font_size_tablet=”40px” first_heading_font_size_phone=”30px” first_heading_font_size_last_edited=”on|phone” second_heading_font_size_tablet=”” second_heading_font_size_phone=”” second_heading_font_size_last_edited=”on|phone” global_colors_info=”{}”][\/dipi_dual_heading][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” da_disable_devices=”off|off|off” locked=”off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row column_structure=”1_4,3_4″ use_custom_gutter=”on” gutter_width=”2″ _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”0px||0px||true|false” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/meeting.anztct.org.au\/2025\/wp-content\/uploads\/sites\/4\/2025\/07\/anztct-2025-amit-khot-500px.jpg” alt=”Amit Khot” title_text=”Amit Khot” _builder_version=”4.27.4″ _module_preset=”default” border_radii=”on|50%|50%|50%|50%” border_width_all=”5px” border_color_all=”#303F9F” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][dipi_dual_heading first_heading=”Local speaker” second_heading=”About A\/Prof Amit Khot” heading_display=”column” fh_style=”background” first_heading_color=”#E8EAF6″ _builder_version=”4.27.4″ _module_preset=”default” first_heading_font=”|||on|||||” first_heading_font_size=”11px” first_heading_letter_spacing=”1px” text_orientation=”left” custom_margin=”||10px||false|false” custom_padding=”||0px||false|false” global_colors_info=”{}”][\/dipi_dual_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]After graduating from the University of Pune, India, A\/Prof Amit Khot trained in Internal Medicine in India and the UK, where he qualified as a Member of the Royal College of Physicians. He
\ncompleted training in laboratory and clinical haematology in London, UK, obtaining a Fellowship from the Royal College of Pathologists. This was followed by a BMT fellowship at the Royal Marsden Hospital, London and a clinical research fellowship involving early phase clinical trials in cell therapies and myeloma at the Peter MacCallum Cancer Centre, Melbourne. Amit\u2019s areas of interest include cell therapies, bone marrow transplantation, myeloma, T-cell lymphoma. He currently works as a Consultant Haematologist at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital and is an investigator in clinical trials, including first-in-human early phase studies involving novel agents and immunotherapies.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
Consultant Haematologist at the Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne<\/p>\n","protected":false},"author":8,"featured_media":429,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"2880","footnotes":""},"categories":[12],"tags":[],"dipi_cpt_category":[],"class_list":["post-430","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-speaker"],"yoast_head":"\n